These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26650885)

  • 1. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
    Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF
    AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.
    Morrison CS; Fichorova R; Chen PL; Kwok C; Deese J; Yamamoto H; Anderson S; Chipato T; Salata R; Doncel GF
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):889-899. PubMed ID: 30047279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
    Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
    PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion.
    Govender Y; Morrison CS; Chen PL; Gao X; Yamamoto H; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
    Sex Transm Infect; 2023 Aug; 99(5):311-316. PubMed ID: 36104248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
    Morrison CS; Chen PL; Yamamoto H; Gao X; Chipato T; Anderson S; Barbieri R; Salata R; Doncel GF; Fichorova RN
    J Acquir Immune Defic Syndr; 2020 May; 84(1):85-91. PubMed ID: 31985699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.
    Mitchell C; Hitti J; Paul K; Agnew K; Cohn SE; Luque AE; Coombs R
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):35-9. PubMed ID: 20929397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
    Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
    mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.
    Bull ME; Legard J; Tapia K; Sorensen B; Cohn SE; Garcia R; Holte SE; Coombs RW; Hitti JE
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):357-64. PubMed ID: 25202922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
    Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
    AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women.
    Ghosh M; Daniels J; Pyra M; Juzumaite M; Jais M; Murphy K; Taylor TN; Kassaye S; Benning L; Cohen M; Weber K
    PLoS One; 2018; 13(6):e0198412. PubMed ID: 29894487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital inflammation and the risk of HIV acquisition in women.
    Masson L; Passmore JA; Liebenberg LJ; Werner L; Baxter C; Arnold KB; Williamson C; Little F; Mansoor LE; Naranbhai V; Lauffenburger DA; Ronacher K; Walzl G; Garrett NJ; Williams BL; Couto-Rodriguez M; Hornig M; Lipkin WI; Grobler A; Abdool Karim Q; Abdool Karim SS
    Clin Infect Dis; 2015 Jul; 61(2):260-9. PubMed ID: 25900168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
    Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
    Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
    Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
    J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.
    Mitchell C; Balkus JE; McKernan-Mullin J; Cohn SE; Luque AE; Mwachari C; Cohen CR; Coombs R; Frenkel LM; Hitti J
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):143-8. PubMed ID: 23018377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Patel EU; Kirkpatrick AR; Grabowski MK; Kigozi G; Gray RH; Prodger JL; Redd AD; Nalugoda F; Serwadda D; Wawer MJ; Quinn TC; Tobian AA
    Clin Infect Dis; 2017 Mar; 64(6):776-784. PubMed ID: 28011606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.